US Patent Issued to Miltenyi Biotec on March 11 for "Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hematopoietic cells that have a modified or deleted target antigen" (German Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,246,065, issued on March 11, was assigned to Miltenyi Biotec B.V. & Co. Kg (Bergisch Gladbach, Germany).

"Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hematopoietic cells that have a modified or deleted target antigen" was invented by Michael Lutteropp (Bergisch Gladbach, Germany), Anne Richter (Bergisch Gladbach, Germany), Andrew Kaiser (Bergisch Gladbach, Germany), Mario Assenmacher (Bergisch Gladbach, Germany) and Stefan Miltenyi (Bergisch Gladbach, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a system that comprises pharmaceutical agents for use in immunotherapy for reducing the side-ef...